Viewing Study NCT05126966

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2026-01-22 @ 9:26 AM
Study NCT ID: NCT05126966
Status: WITHDRAWN
Last Update Posted: 2024-01-18
First Post: 2021-10-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
Sponsor: Hoffmann-La Roche
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular Age-Related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Wet AMD View
None neovascular AMD View
None exudative AMD View